{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T07:55:59Z","timestamp":1793174159532,"version":"4.5.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,5]],"date-time":"2022-02-05T00:00:00Z","timestamp":1644019200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,5]],"date-time":"2022-02-05T00:00:00Z","timestamp":1644019200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AG065928"],"award-info":[{"award-number":["AG065928"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AG066574"],"award-info":[{"award-number":["AG066574"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001011","name":"Joe W. and Dorothy Dorsett Brown Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001011","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000863","name":"The Ellison Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000863","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Fluids Barriers CNS"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Human induced pluripotent stem cell (hiPSC)-derived brain endothelial-like cells (iBECs) are a robust, scalable, and translatable model of the human blood\u2013brain barrier (BBB). Prior works have shown that high transendothelial electrical resistance (TEER) persists in iBECs for at least 2\u00a0weeks, emphasizing the utility of the model for longer term studies. However, most studies evaluate iBECs within the first few days of subculture, and little is known about their proliferative state, which could influence their functions. In this study, we characterized iBEC proliferative state in relation to key BBB properties at early (2\u00a0days) and late (9\u00a0days) post-subculture time points.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      hiPSCs were differentiated into iBECs using fully defined, serum-free medium. The proportion of proliferating cells was determined by BrdU assays. We evaluated TEER, expression of glycolysis enzymes and tight and adherens junction proteins (TJP and AJP), and glucose transporter-1 (GLUT1) function by immunoblotting, immunofluorescence, and quantifying radiolabeled tracer permeabilities. We also compared barrier disruption in response to TNF-\u03b1 and conditioned medium (CM) from hiPSC-derived neurons harboring the Alzheimer\u2019s disease (AD)-causing Swedish mutation (APP\n                      <jats:sup>Swe\/+<\/jats:sup>\n                      ).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A significant decline in iBEC proliferation over time in culture was accompanied by adoption of a more quiescent endothelial metabolic state, indicated by downregulation of glycolysis-related proteins and upregulation GLUT1. Interestingly, upregulation of GLUT1 was associated with reduced glucose transport rates in more quiescent iBECs. We also found significant decreases in claudin-5 (CLDN5) and vascular endothelial-cadherin (VE-Cad) and a trend toward a decrease in platelet endothelial cell adhesion molecule-1 (PECAM-1), whereas zona occludens-1 (ZO-1) increased and occludin (OCLN) remained unchanged. Despite differences in TJP and AJP expression, there was no difference in mean TEER on day 2 vs. day 9. TNF-\u03b1 induced disruption irrespective of iBEC proliferative state. Conversely, APP\n                      <jats:sup>Swe\/+<\/jats:sup>\n                      CM disrupted only proliferating iBEC monolayers.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>iBECs can be used to study responses to disease-relevant stimuli in proliferating vs. more quiescent endothelial cell states, which may provide insight into BBB vulnerabilities in contexts of development, brain injury, and neurodegenerative disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12987-022-00307-1","type":"journal-article","created":{"date-parts":[[2022,2,5]],"date-time":"2022-02-05T06:02:42Z","timestamp":1644040962000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Prolonged culturing of iPSC-derived brain endothelial-like cells is associated with quiescence, downregulation of glycolysis, and resistance to disruption by an Alzheimer\u2019s brain milieu"],"prefix":"10.1186","volume":"19","author":[{"given":"Lindsey M.","family":"Williams","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riley R.","family":"Weaver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aric F.","family":"Logsdon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kira M.","family":"Evitts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica E.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William A.","family":"Banks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2575-1594","authenticated-orcid":false,"given":"Michelle A.","family":"Erickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,5]]},"reference":[{"issue":"1","key":"307_CR1","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1152\/physrev.00050.2017","volume":"99","author":"MD Sweeney","year":"2019","unstructured":"Sweeney MD, Zhao Z, Montagne A, Nelson AR, Zlokovic BV. Blood\u2013brain barrier: from physiology to disease and back. Physiol Rev. 2019;99(1):21\u201378.","journal-title":"Physiol Rev"},{"issue":"3","key":"307_CR2","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s00401-018-1815-1","volume":"135","author":"S Liebner","year":"2018","unstructured":"Liebner S, Dijkhuizen RM, Reiss Y, Plate KH, Agalliu D, Constantin G. Functional morphology of the blood\u2013brain barrier in health and disease. Acta Neuropathol. 2018;135(3):311\u201336.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"307_CR3","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12987-020-00187-3","volume":"17","author":"MA Erickson","year":"2020","unstructured":"Erickson MA, Wilson ML, Banks WA. In vitro modeling of blood\u2013brain barrier and interface functions in neuroimmune communication. Fluids Barriers CNS. 2020;17(1):26.","journal-title":"Fluids Barriers CNS"},{"issue":"7501","key":"307_CR4","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/nature13324","volume":"509","author":"A Ben-Zvi","year":"2014","unstructured":"Ben-Zvi A, Lacoste B, Kur E, Andreone BJ, Mayshar Y, Yan H, et al. Mfsd2a is critical for the formation and function of the blood\u2013brain barrier. Nature. 2014;509(7501):507\u201311.","journal-title":"Nature"},{"issue":"2","key":"307_CR5","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1124\/pr.117.014647","volume":"70","author":"MA Erickson","year":"2018","unstructured":"Erickson MA, Banks WA. Neuroimmune axes of the blood\u2013brain barriers and blood-brain interfaces: bases for physiological regulation, disease states, and pharmacological interventions. Pharmacol Rev. 2018;70(2):278\u2013314.","journal-title":"Pharmacol Rev"},{"issue":"4","key":"307_CR6","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.stemcr.2017.02.021","volume":"8","author":"A Appelt-Menzel","year":"2017","unstructured":"Appelt-Menzel A, Cubukova A, G\u00fcnther K, Edenhofer F, Piontek J, Krause G, et al. Establishment of a human blood\u2013brain barrier co-culture model mimicking the neurovascular unit using induced pluri- and multipotent stem cells. Stem Cell Rep. 2017;8(4):894\u2013906.","journal-title":"Stem Cell Rep"},{"issue":"7","key":"307_CR7","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1016\/j.celrep.2017.04.021","volume":"19","author":"RG Lim","year":"2017","unstructured":"Lim RG, Quan C, Reyes-Ortiz AM, Lutz SE, Kedaigle AJ, Gipson TA, et al. Huntington\u2019s disease iPSC-derived brain microvascular endothelial cells reveal WNT-mediated angiogenic and blood\u2013brain barrier deficits. Cell Rep. 2017;19(7):1365\u201377.","journal-title":"Cell Rep"},{"issue":"6","key":"307_CR8","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.stem.2017.04.002","volume":"20","author":"GD Vatine","year":"2017","unstructured":"Vatine GD, Al-Ahmad A, Barriga BK, Svendsen S, Salim A, Garcia L, et al. Modeling psychomotor retardation using iPSCs from MCT8-deficient patients indicates a prominent role for the blood\u2013brain barrier. Cell Stem Cell. 2017;20(6):831\u201343.","journal-title":"Cell Stem Cell"},{"issue":"1","key":"307_CR9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12987-020-00235-y","volume":"18","author":"S Raut","year":"2021","unstructured":"Raut S, Patel R, Al-Ahmad AJ. Presence of a mutation in PSEN1 or PSEN2 gene is associated with an impaired brain endothelial cell phenotype in vitro. Fluids Barriers CNS. 2021;18(1):3.","journal-title":"Fluids Barriers CNS"},{"issue":"1","key":"307_CR10","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12987-019-0139-4","volume":"16","author":"ME Katt","year":"2019","unstructured":"Katt ME, Mayo LN, Ellis SE, Mahairaki V, Rothstein JD, Cheng L, et al. The role of mutations associated with familial neurodegenerative disorders on blood\u2013brain barrier function in an iPSC model. Fluids Barriers CNS. 2019;16(1):20.","journal-title":"Fluids Barriers CNS"},{"issue":"5","key":"307_CR11","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.stemcr.2020.03.011","volume":"14","author":"LE Oikari","year":"2020","unstructured":"Oikari LE, Pandit R, Stewart R, Cun\u00ed-L\u00f3pez C, Quek H, Sutharsan R, et al. Altered brain endothelial cell phenotype from a familial Alzheimer mutation and its potential implications for amyloid clearance and drug delivery. Stem Cell Rep. 2020;14(5):924\u201339.","journal-title":"Stem Cell Rep"},{"issue":"8","key":"307_CR12","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/nbt.2247","volume":"30","author":"ES Lippmann","year":"2012","unstructured":"Lippmann ES, Azarin SM, Kay JE, Nessler RA, Wilson HK, Al-Ahmad A, et al. Derivation of blood\u2013brain barrier endothelial cells from human pluripotent stem cells. Nat Biotechnol. 2012;30(8):783\u201391.","journal-title":"Nat Biotechnol"},{"key":"307_CR13","doi-asserted-by":"publisher","first-page":"4160","DOI":"10.1038\/srep04160","volume":"4","author":"ES Lippmann","year":"2014","unstructured":"Lippmann ES, Al-Ahmad A, Azarin SM, Palecek SP, Shusta EV. A retinoic acid-enhanced, multicellular human blood\u2013brain barrier model derived from stem cell sources. Sci Rep. 2014;4:4160.","journal-title":"Sci Rep"},{"issue":"1","key":"307_CR14","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12987-017-0059-0","volume":"14","author":"EK Hollmann","year":"2017","unstructured":"Hollmann EK, Bailey AK, Potharazu AV, Neely MD, Bowman AB, Lippmann ES. Accelerated differentiation of human induced pluripotent stem cells to blood\u2013brain barrier endothelial cells. Fluids Barriers CNS. 2017;14(1):9.","journal-title":"Fluids Barriers CNS"},{"issue":"6","key":"307_CR15","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1016\/j.stemcr.2019.05.008","volume":"12","author":"EH Neal","year":"2019","unstructured":"Neal EH, Marinelli NA, Shi Y, McClatchey PM, Balotin KM, Gullett DR, et al. A simplified, fully defined differentiation scheme for producing blood\u2013brain barrier endothelial cells from human iPSCs. Stem Cell Rep. 2019;12(6):1380\u20138.","journal-title":"Stem Cell Rep"},{"issue":"4","key":"307_CR16","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/nn.3966","volume":"18","author":"EA Winkler","year":"2015","unstructured":"Winkler EA, Nishida Y, Sagare AP, Rege SV, Bell RD, Perlmutter D, et al. GLUT1 reductions exacerbate Alzheimer\u2019s disease vasculo-neuronal dysfunction and degeneration. Nat Neurosci. 2015;18(4):521\u201330.","journal-title":"Nat Neurosci"},{"issue":"9","key":"307_CR17","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1007\/s00424-020-02441-x","volume":"472","author":"H Koepsell","year":"2020","unstructured":"Koepsell H. Glucose transporters in brain in health and disease. Pflugers Arch. 2020;472(9):1299\u2013343.","journal-title":"Pflugers Arch"},{"issue":"1","key":"307_CR18","doi-asserted-by":"publisher","first-page":"17490","DOI":"10.1038\/s41598-017-17718-y","volume":"7","author":"M Gejl","year":"2017","unstructured":"Gejl M, Brock B, Egefjord L, Vang K, Rungby J, Gjedde A. Blood\u2013brain glucose transfer in Alzheimer\u2019s disease: effect of GLP-1 analog treatment. Sci Rep. 2017;7(1):17490.","journal-title":"Sci Rep"},{"issue":"37","key":"307_CR19","first-page":"9448","volume":"26","author":"JE Westin","year":"2006","unstructured":"Westin JE, Lindgren HS, Gardi J, Nyengaard JR, Brundin P, Mohapel P, et al. Endothelial proliferation and increased blood-brain barrier permeability in the basal ganglia in a rat model of 3,4-dihydroxyphenyl-lalanine-induced dyskinesia. J Neurosci Res. 2006;26(37):9448\u201361.","journal-title":"J Neurosci Res"},{"issue":"1","key":"307_CR20","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s40478-020-01051-z","volume":"8","author":"SK Halder","year":"2020","unstructured":"Halder SK, Milner R. Mild hypoxia triggers transient blood-brain barrier disruption: a fundamental protective role for microglia. Acta Neuropathol Commun. 2020;8(1):175.","journal-title":"Acta Neuropathol Commun"},{"key":"307_CR21","doi-asserted-by":"publisher","first-page":"652647","DOI":"10.3389\/fncel.2021.652647","volume":"15","author":"H Zhu","year":"2021","unstructured":"Zhu H, Zhang Y, Zhong Y, Ye Y, Hu X, Gu L, et al. Inflammation-mediated angiogenesis in ischemic stroke. Front Cell Neurosci. 2021;15:652647.","journal-title":"Front Cell Neurosci"},{"key":"307_CR22","doi-asserted-by":"publisher","first-page":"618986","DOI":"10.3389\/fncel.2020.618986","volume":"14","author":"J Steinman","year":"2021","unstructured":"Steinman J, Sun HS, Feng ZP. Microvascular alterations in Alzheimer\u2019s disease. Front Cell Neurosci. 2021;14:618986.","journal-title":"Front Cell Neurosci"},{"issue":"1","key":"307_CR23","doi-asserted-by":"publisher","first-page":"234","DOI":"10.3390\/ijms21010234","volume":"21","author":"B Pajak","year":"2019","unstructured":"Pajak B, Siwiak E, So\u0142tyka M, Priebe A, Zieli\u0144ski R, Fokt I, et al. 2-Deoxy-d-glucose and its analogs: from diagnostic to therapeutic agents. Int J Mol Sci. 2019;21(1):234.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"307_CR24","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1111\/j.1471-4159.1990.tb01236.x","volume":"54","author":"MP Dehouck","year":"1990","unstructured":"Dehouck MP, M\u00e9resse S, Delorme P, Fruchart JC, Cecchelli R. An easier, reproducible, and mass-production method to study the blood\u2013brain barrier in vitro. J Neurochem. 1990;54(5):1798\u2013801.","journal-title":"J Neurochem"},{"issue":"3","key":"307_CR25","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.stemcr.2018.01.031","volume":"10","author":"JE Young","year":"2018","unstructured":"Young JE, Fong LK, Frankowski H, Petsko GA, Small SA, Goldstein LSB. Stabilizing the retromer complex in a human stem cell model of Alzheimer\u2019s disease reduces TAU phosphorylation independently of amyloid precursor protein. Stem Cell Rep. 2018;10(3):1046\u201358.","journal-title":"Stem Cell Rep"},{"issue":"9","key":"307_CR26","doi-asserted-by":"publisher","first-page":"107719","DOI":"10.1016\/j.celrep.2020.107719","volume":"31","author":"A Knupp","year":"2020","unstructured":"Knupp A, Mishra S, Martinez R, Braggin JE, Szabo M, Kinoshita C, et al. Depletion of the AD Risk Gene SORL1 selectively impairs neuronal endosomal traffic independent of amyloidogenic APP processing. Cell Rep. 2020;31(9):107719.","journal-title":"Cell Rep"},{"issue":"1","key":"307_CR27","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/jnr.24615","volume":"99","author":"GX D'Souza","year":"2021","unstructured":"D\u2019Souza GX, Rose SE, Knupp A, Nicholson DA, Keene CD, Young JE. The application of in vitro-derived human neurons in neurodegenerative disease modeling. J Neurosci Res. 2021;99(1):124\u201340.","journal-title":"J Neurosci Res"},{"issue":"8","key":"307_CR28","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s41569-021-00517-4","volume":"18","author":"N Ricard","year":"2021","unstructured":"Ricard N, Bailly S, Guignabert C, Simons M. The quiescent endothelium: signalling pathways regulating organ-specific endothelial normalcy. Nat Rev Cardiol. 2021;18(8):565\u201380.","journal-title":"Nat Rev Cardiol"},{"issue":"4","key":"307_CR29","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1161\/CIRCRESAHA.119.316463","volume":"127","author":"K Veys","year":"2020","unstructured":"Veys K, Fan Z, Ghobrial M, Bouch\u00e9 A, Garc\u00eda-Caballero M, Conchinha NV, Vriens K, et al. Role of the GLUT1 glucose transporter in postnatal CNS angiogenesis and blood\u2013brain barrier integrity. Circ Res. 2020;127(4):466\u201382.","journal-title":"Circ Res"},{"issue":"1","key":"307_CR30","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1152\/physrev.00001.2017","volume":"98","author":"G Eelen","year":"2018","unstructured":"Eelen G, de Zeeuw P, Treps L, Harjes U, Wong BW, Carmeliet P. Endothelial cell metabolism. Physiol Rev. 2018;98(1):3\u201358.","journal-title":"Physiol Rev"},{"issue":"3","key":"307_CR31","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.cell.2013.06.037","volume":"154","author":"K De Bock","year":"2013","unstructured":"De Bock K, Georgiadou M, Schoors S, Kuchnio A, Wong BW, Cantelmo AR, et al. Role of PFKFB3-driven glycolysis in vessel sprouting. Cell. 2013;154(3):651\u201363.","journal-title":"Cell"},{"issue":"1","key":"307_CR32","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/s41467-017-02733-4","volume":"9","author":"D DeWaal","year":"2018","unstructured":"DeWaal D, Nogueira V, Terry AR, Patra KC, Jeon SM, Guzman G, et al. Hexokinase-2 depletion inhibits glycolysis and induces oxidative phosphorylation in hepatocellular carcinoma and sensitizes to metformin. Nat Commun. 2018;9(1):446.","journal-title":"Nat Commun"},{"issue":"10","key":"307_CR33","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1016\/j.bbamcr.2016.03.013","volume":"1863","author":"J P\u00e9rez-Escuredo","year":"2016","unstructured":"P\u00e9rez-Escuredo J, Van H\u00e9e VF, Sboarina M, Falces J, Payen VL, Pellerin L, et al. Monocarboxylate transporters in the brain and in cancer. Biochim Biophys Acta. 2016;1863(10):2481\u201397.","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"307_CR34","doi-asserted-by":"publisher","first-page":"141","DOI":"10.4048\/jbc.2012.15.2.141","volume":"15","author":"F Aghaee","year":"2012","unstructured":"Aghaee F, Pirayesh Islamian J, Baradaran B. Enhanced radiosensitivity and chemosensitivity of breast cancer cells by 2-deoxy-d-glucose in combination therapy. J Breast Cancer. 2012;15(2):141\u20137.","journal-title":"J Breast Cancer"},{"issue":"4","key":"307_CR35","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/nrn785","volume":"3","author":"SS Sisodia","year":"2002","unstructured":"Sisodia SS, St George-Hyslop PH. gamma-Secretase, Notch, Abeta and Alzheimer\u2019s disease: where do the presenilins fit in? Nat Rev Neurosci. 2002;3(4):281\u201390.","journal-title":"Nat Rev Neurosci"},{"issue":"3","key":"307_CR36","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.neulet.2008.06.061","volume":"441","author":"M Balcells","year":"2008","unstructured":"Balcells M, Wallins JS, Edelman ER. Amyloid beta toxicity dependent upon endothelial cell state. Neurosci Lett. 2008;441(3):319\u201322.","journal-title":"Neurosci Lett"},{"issue":"17","key":"307_CR37","doi-asserted-by":"publisher","first-page":"7212","DOI":"10.18632\/oncotarget.2446","volume":"5","author":"P Sun","year":"2014","unstructured":"Sun P. Contact inhibition against senescence. Oncotarget. 2014;5(17):7212\u20133.","journal-title":"Oncotarget"},{"issue":"26","key":"307_CR38","doi-asserted-by":"publisher","first-page":"22480","DOI":"10.18632\/oncotarget.4310","volume":"6","author":"S Krishnan","year":"2015","unstructured":"Krishnan S, Szabo E, Burghardt I, Frei K, Tabatabai G, Weller M. Modulation of cerebral endothelial cell function by TGF-\u03b2 in glioblastoma: VEGF-dependent angiogenesis versus endothelial mesenchymal transition. Oncotarget. 2015;6(26):22480\u201395.","journal-title":"Oncotarget"},{"issue":"12","key":"307_CR39","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1111\/cns.12764","volume":"23","author":"SC Ma","year":"2017","unstructured":"Ma SC, Li Q, Peng JY, Zhouwen JL, Diao JF, Niu JX, et al. Claudin-5 regulates blood-brain barrier permeability by modifying brain microvascular endothelial cell proliferation, migration, and adhesion to prevent lung cancer metastasis. CNS Neurosci Ther. 2017;23(12):947\u201360.","journal-title":"CNS Neurosci Ther"},{"issue":"3","key":"307_CR40","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1083\/jcb.200302070","volume":"161","author":"T Nitta","year":"2003","unstructured":"Nitta T, Hata M, Gotoh S, Seo Y, Sasaki H, Hashimoto N, et al. Size-selective loosening of the blood\u2013brain barrier in claudin-5-deficient mice. J Cell Biol. 2003;161(3):653\u201360.","journal-title":"J Cell Biol"},{"issue":"1","key":"307_CR41","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.yexcr.2004.07.012","volume":"300","author":"T Soma","year":"2004","unstructured":"Soma T, Chiba H, Kato-Mori Y, Wada T, Yamashita T, Kojima T, et al. Thr(207) of claudin-5 is involved in size-selective loosening of the endothelial barrier by cyclic AMP. Exp Cell Res. 2004;300(1):202\u201312.","journal-title":"Exp Cell Res"},{"key":"307_CR42","doi-asserted-by":"publisher","first-page":"392","DOI":"10.3389\/fnins.2014.00392","volume":"8","author":"HC Bauer","year":"2014","unstructured":"Bauer HC, Krizbai IA, Bauer H, Traweger A. \u201cYou Shall Not Pass\"-tight junctions of the blood brain barrier. Front Neurosci. 2014;8:392.","journal-title":"Front Neurosci"},{"issue":"5","key":"307_CR43","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1290\/1071-2690(2002)038<0273:IAMCOB>2.0.CO;2","volume":"38","author":"RE Unger","year":"2002","unstructured":"Unger RE, Oltrogge JB, von Briesen H, Engelhardt B, Woelki U, Schlote W, et al. Isolation and molecular characterization of brain microvascular endothelial cells from human brain tumors. In Vitro Cell Dev Biol Anim. 2002;38(5):273\u201381.","journal-title":"In Vitro Cell Dev Biol Anim"},{"issue":"20","key":"307_CR44","doi-asserted-by":"publisher","first-page":"10779","DOI":"10.1073\/pnas.93.20.10779","volume":"93","author":"CJ Gottardi","year":"1996","unstructured":"Gottardi CJ, Arpin M, Fanning AS, Louvard D. The junction-associated protein, zonula occludens-1, localizes to the nucleus before the maturation and during the remodeling of cell\u2013cell contacts. Proc Natl Acad Sci USA. 1996;93(20):10779\u201384.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"307_CR45","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1128\/MCB.26.6.2387-2398.2006","volume":"26","author":"T Sourisseau","year":"2006","unstructured":"Sourisseau T, Georgiadis A, Tsapara A, Ali RR, Pestell R, Matter K, et al. Regulation of PCNA and cyclin D1 expression and epithelial morphogenesis by the ZO-1-regulated transcription factor ZONAB\/DbpA. Mol Cell Biol. 2006;26(6):2387\u201398.","journal-title":"Mol Cell Biol"},{"issue":"9","key":"307_CR46","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1038\/sj.emboj.7600647","volume":"24","author":"U Baumeister","year":"2005","unstructured":"Baumeister U, Funke R, Ebnet K, Vorschmitt H, Koch S, Vestweber D. Association of Csk to VE-cadherin and inhibition of cell proliferation. EMBO J. 2005;24(9):1686\u201395.","journal-title":"EMBO J"},{"issue":"28","key":"307_CR47","doi-asserted-by":"publisher","first-page":"19053","DOI":"10.1074\/jbc.M109.000521","volume":"284","author":"SM Stamatovic","year":"2009","unstructured":"Stamatovic SM, Keep RF, Wang MM, Jankovic I, Andjelkovic AV. Caveolae-mediated internalization of occludin and claudin-5 during CCL2-induced tight junction remodeling in brain endothelial cells. J Biol Chem. 2009;284(28):19053\u201366.","journal-title":"J Biol Chem"},{"issue":"2","key":"307_CR48","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s00441-003-0825-y","volume":"315","author":"S Hamm","year":"2004","unstructured":"Hamm S, Dehouck B, Kraus J, Wolburg-Buchholz K, Wolburg H, Risau W, et al. Astrocyte mediated modulation of blood-brain barrier permeability does not correlate with a loss of tight junction proteins from the cellular contacts. Cell Tissue Res. 2004;315(2):157\u201366.","journal-title":"Cell Tissue Res"},{"key":"307_CR49","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1146\/annurev.neuro.22.1.11","volume":"22","author":"LL Rubin","year":"1999","unstructured":"Rubin LL, Staddon JM. The cell biology of the blood\u2013brain barrier. Annu Rev Neurosci. 1999;22:11\u201328.","journal-title":"Annu Rev Neurosci"},{"issue":"8","key":"307_CR50","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.tem.2020.05.009","volume":"31","author":"SJ Dumas","year":"2020","unstructured":"Dumas SJ, Garc\u00eda-Caballero M, Carmeliet P. Metabolic signatures of distinct endothelial phenotypes. Trends Endocrinol Metab. 2020;31(8):580\u201395.","journal-title":"Trends Endocrinol Metab"},{"issue":"12","key":"307_CR51","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.2337\/diab.44.12.1399","volume":"44","author":"AK Kumagai","year":"1995","unstructured":"Kumagai AK, Kang YS, Boado RJ, Pardridge WM. Upregulation of blood-brain barrier GLUT1 glucose transporter protein and mRNA in experimental chronic hypoglycemia. Diabetes. 1995;44(12):1399\u2013404.","journal-title":"Diabetes"},{"issue":"7653","key":"307_CR52","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/nature22322","volume":"545","author":"P Yu","year":"2017","unstructured":"Yu P, Wilhelm K, Dubrac A, Tung JK, Alves TC, Fang JS, et al. FGF-dependent metabolic control of vascular development. Nature. 2017;545(7653):224\u20138.","journal-title":"Nature"},{"key":"307_CR53","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.molmet.2019.07.006","volume":"33","author":"VL Payen","year":"2020","unstructured":"Payen VL, Mina E, Van H\u00e9e VF, Porporato PE, Sonveaux P. Monocarboxylate transporters in cancer. Mol Metab. 2020;33:48\u201366.","journal-title":"Mol Metab."},{"issue":"12","key":"307_CR54","doi-asserted-by":"publisher","first-page":"2630","DOI":"10.1002\/mc.22707","volume":"56","author":"V Miranda-Gon\u00e7alves","year":"2017","unstructured":"Miranda-Gon\u00e7alves V, Bezerra F, Costa-Almeida R, Freitas-Cunha M, Soares R, Martinho O, et al. Monocarboxylate transporter 1 is a key player in glioma-endothelial cell crosstalk. Mol Carcinog. 2017;56(12):2630\u20132642s.","journal-title":"Mol Carcinog"},{"issue":"13","key":"307_CR55","doi-asserted-by":"publisher","first-page":"5779","DOI":"10.1073\/pnas.88.13.5779","volume":"88","author":"CL Farrell","year":"1991","unstructured":"Farrell CL, Pardridge WM. Blood\u2013brain barrier glucose transporter is asymmetrically distributed on brain capillary endothelial lumenal and ablumenal membranes: an electron microscopic immunogold study. Proc Natl Acad Sci USA. 1991;88(13):5779\u201383.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"307_CR56","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1038\/jcbfm.1993.106","volume":"13","author":"EM Cornford","year":"1993","unstructured":"Cornford EM, Hyman S, Pardridge WM. An electron microscopic immunogold analysis of developmental up-regulation of the blood\u2013brain barrier GLUT1 glucose transporter. J Cereb Blood Flow Metab. 1993;13(5):841\u201354.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"4","key":"307_CR57","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1002\/jnr.490220413","volume":"22","author":"DZ Gerhart","year":"1989","unstructured":"Gerhart DZ, LeVasseur RJ, Broderius MA, Drewes LR. Glucose transporter localization in brain using light and electron immunocytochemistry. J Neurosci Res. 1989;22(4):464\u201372.","journal-title":"J Neurosci Res"},{"issue":"1","key":"307_CR58","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1602\/neurorx.2.1.27","volume":"2","author":"EM Cornford","year":"2005","unstructured":"Cornford EM, Hyman S. Localization of brain endothelial luminal and abluminal transporters with immunogold electron microscopy. NeuroRx. 2005;2(1):27\u201343.","journal-title":"NeuroRx"},{"issue":"7","key":"307_CR59","first-page":"1876","volume":"41","author":"H Sone","year":"2000","unstructured":"Sone H, Deo BK, Kumagai AK. Enhancement of glucose transport by vascular endothelial growth factor in retinal endothelial cells. Invest Ophthalmol Vis Sci. 2000;41(7):1876\u201384.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"307_CR60","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1007\/s12035-015-9672-6","volume":"54","author":"SG Patching","year":"2017","unstructured":"Patching SG. Glucose transporters at the blood\u2013brain barrier: function, regulation and gateways for drug delivery. Mol Neurobiol. 2017;54(2):1046\u201377.","journal-title":"Mol Neurobiol"},{"issue":"7","key":"307_CR61","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.3390\/jcm10071532","volume":"10","author":"E Rebelos","year":"2021","unstructured":"Rebelos E, Rinne JO, Nuutila P, Ekblad LL. Brain glucose metabolism in health, obesity, and cognitive decline-does insulin have anything to do with it? A narrative review. J Clin Med. 2021;10(7):1532.","journal-title":"J Clin Med"},{"issue":"1","key":"307_CR62","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.jalz.2018.07.222","volume":"15","author":"MD Sweeney","year":"2019","unstructured":"Sweeney MD, Montagne A, Sagare AP, Nation DA, Schneider LS, Chui HC, et al. Vascular dysfunction\u2014the disregarded partner of Alzheimer\u2019s disease. Alzheimers Dement. 2019;15(1):158\u201367.","journal-title":"Alzheimers Dement"},{"key":"307_CR63","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.eplepsyres.2014.11.007","volume":"110","author":"CI Akman","year":"2015","unstructured":"Akman CI, Provenzano F, Wang D, Engelstad K, Hinton V, Yu J, et al. Topography of brain glucose hypometabolism and epileptic network in glucose transporter 1 deficiency. Epilepsy Res. 2015;110:206\u201315.","journal-title":"Epilepsy Res"},{"issue":"1","key":"307_CR64","doi-asserted-by":"publisher","first-page":"35","DOI":"10.4149\/endo_2014_01_35","volume":"48","author":"J Jurcovicova","year":"2014","unstructured":"Jurcovicova J. Glucose transport in brain\u2014effect of inflammation. Endocr Regul. 2014;48(1):35\u201348.","journal-title":"Endocr Regul"},{"issue":"27","key":"307_CR65","doi-asserted-by":"publisher","first-page":"7033","DOI":"10.1073\/pnas.1803859115","volume":"115","author":"Q Yan","year":"2018","unstructured":"Yan Q, Lu Y, Zhou L, Chen J, Xu H, Cai M, et al. Mechanistic insights into GLUT1 activation and clustering revealed by super-resolution imaging. Proc Natl Acad Sci USA. 2018;115(27):7033\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"307_CR66","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.molcel.2015.04.015","volume":"58","author":"EE Lee","year":"2015","unstructured":"Lee EE, Ma J, Sacharidou A, Mi W, Salato VK, Nguyen N, et al. A protein kinase C phosphorylation motif in GLUT1 affects glucose transport and is mutated in GLUT1 deficiency syndrome. Mol Cell. 2015;58(5):845\u201353.","journal-title":"Mol Cell"},{"key":"307_CR67","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.nbd.2018.07.030","volume":"119","author":"JL Mantle","year":"2018","unstructured":"Mantle JL, Lee KH. A differentiating neural stem cell-derived astrocytic population mitigates the inflammatory effects of TNF-\u03b1 and IL-6 in an iPSC-based blood\u2013brain barrier model. Neurobiol Dis. 2018;119:113\u201320.","journal-title":"Neurobiol Dis"},{"issue":"9","key":"307_CR68","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1016\/j.bbadis.2014.06.029","volume":"1842","author":"H Qosa","year":"2014","unstructured":"Qosa H, LeVine H 3rd, Keller JN, Kaddoumi A. Mixed oligomers and monomeric amyloid-\u03b2 disrupts endothelial cells integrity and reduces monomeric amyloid-\u03b2 transport across hCMEC\/D3 cell line as an in vitro blood-brain barrier model. Biochim Biophys Acta. 2014;1842(9):1806\u201315.","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"307_CR69","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12987-019-0145-6","volume":"16","author":"SG Canfield","year":"2019","unstructured":"Canfield SG, Stebbins MJ, Faubion MG, Gastfriend BD, Palecek SP, Shusta EV. An isogenic neurovascular unit model comprised of human induced pluripotent stem cell-derived brain microvascular endothelial cells, pericytes, astrocytes, and neurons. Fluids Barriers CNS. 2019;16(1):25.","journal-title":"Fluids Barriers CNS"},{"issue":"5","key":"307_CR70","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/s00702-009-0226-9","volume":"116","author":"BS Desai","year":"2009","unstructured":"Desai BS, Schneider JA, Li JL, Carvey PM, Hendey B. Evidence of angiogenic vessels in Alzheimer\u2019s disease. J Neural Transm (Vienna). 2009;116(5):587\u201397.","journal-title":"J Neural Transm (Vienna)"},{"issue":"9","key":"307_CR71","doi-asserted-by":"publisher","first-page":"12743","DOI":"10.1007\/s13277-016-5165-0","volume":"37","author":"I Giusti","year":"2016","unstructured":"Giusti I, Delle Monache S, Di Francesco M, Sanit\u00e0 P, D\u2019Ascenzo S, Gravina GL, et al. From glioblastoma to endothelial cells through extracellular vesicles: messages for angiogenesis. Tumour Biol. 2016;37(9):12743\u201353.","journal-title":"Tumour Biol"},{"issue":"6","key":"307_CR72","doi-asserted-by":"publisher","first-page":"972","DOI":"10.3171\/jns.2001.94.6.0972","volume":"94","author":"U Sure","year":"2001","unstructured":"Sure U, Butz N, Schlegel J, Siegel AM, Wakat JP, Mennel HD, et al. Endothelial proliferation, neoangiogenesis, and potential de novo generation of cerebrovascular malformations. J Neurosurg. 2001;94(6):972\u20137.","journal-title":"J Neurosurg"},{"issue":"41","key":"307_CR73","doi-asserted-by":"publisher","first-page":"25800","DOI":"10.1073\/pnas.2008762117","volume":"117","author":"SF Lau","year":"2020","unstructured":"Lau SF, Cao H, Fu AKY, Ip NY. Single-nucleus transcriptome analysis reveals dysregulation of angiogenic endothelial cells and neuroprotective glia in Alzheimer\u2019s disease. Proc Natl Acad Sci USA. 2020;117(41):25800\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9357","key":"307_CR74","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/S0140-6736(03)12521-4","volume":"361","author":"AH Vagnucci Jr","year":"2003","unstructured":"Vagnucci AH Jr, Li WW. Alzheimer\u2019s disease and angiogenesis. Lancet. 2003;361(9357):605\u20138.","journal-title":"Lancet"}],"container-title":["Fluids and Barriers of the CNS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-022-00307-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12987-022-00307-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-022-00307-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,23]],"date-time":"2022-10-23T19:10:05Z","timestamp":1666552205000},"score":1,"resource":{"primary":{"URL":"https:\/\/fluidsbarrierscns.biomedcentral.com\/articles\/10.1186\/s12987-022-00307-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,5]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["307"],"URL":"https:\/\/doi.org\/10.1186\/s12987-022-00307-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-968596\/v1","asserted-by":"object"}]},"ISSN":["2045-8118"],"issn-type":[{"value":"2045-8118","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,5]]},"assertion":[{"value":"13 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10"}}